Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

MDMA, aka Ecstasy, May Be New Treatment for Autism’s Social Anxiety

May 29, 2015 | by Seth Augenstein, Digital Reporter | News | Comments

A recreational drug known for making people uninhibited and getting them dancing in clubs could get a new use: to help treat social anxiety among autistic adults, according to a new proposal by a group of researchers. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Strongest Statin-Diabetes Link Yet? Not so Fast, Say Some Experts

May 29, 2015 1:50 pm | by Cynthia Fox, Science Editor | Articles | Comments

Out of 26,000 healthy people, those taking statins to control cholesterol were a striking 87 percent more likely to become diabetic, said a recent Journal of General Internal Medicine database study. Read more...

TOPICS:

Drug Discovery Spotlight: Immuno-Oncolytic Therapy Advances; Suicidal Behavior Ends Co-Development of Psoriasis Drug

May 29, 2015 12:24 pm | by Stephanie Guzowski, Editor | News | Comments

From cancer therapies composed of herpes and vaccinia viruses to pharma collaborations that crumbled, here are your headlines this week. Read more…

TOPICS:

Ombitasvir/Paritaprevir/R in Hepatitis C: Indication of Added Benefit in Certain Patients

May 29, 2015 9:43 am | News | Comments

The fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) has been available since January 2015 for the treatment of adults with chronic hepatitis C infection. Read more...

TOPICS:
Advertisement

New Findings Shed Light on Complexities of Emerging Zoonotic Malaria

May 29, 2015 9:29 am | by London School of Hygiene & Tropical Medicine | News | Comments

Genetic discovery could have important implications for how the disease spreads in humans. Read more...

TOPICS:

Scientists Discover Key to Cause of Immune Cell Migration to Wounds

May 29, 2015 9:24 am | by University of Bristol | News | Comments

Researchers found the triggers which lead these cells to react and respond in cell repair. Read more...

TOPICS:

Antibiotic Approved for Treating Infant Abdominal Infections

May 29, 2015 9:16 am | by National Institute of Health | News | Comments

This NIH-funded study evaluated meropenem in children under 3 months. Read more...

TOPICS:

Clementia Advances Natural History Study of Patients with FOP

May 29, 2015 9:10 am | News | Comments

The multi-center, non-interventional, two-part longitudinal study is designed to measure disease progression over three years in patients with FOP. Read more...

TOPICS:

Fighting TB - South Africa's 'Insidious Epidemic'

May 29, 2015 9:03 am | by University of Oxford | News | Comments

South Africa stands at the center of a global TB epidemic devastating the health of millions and their communities. Read more...

TOPICS:
Advertisement

Teva to Pay $1.2B in Drug-Delay Settlement

May 29, 2015 8:54 am | by Matthew Perrone, AP Health Writer | News | Comments

Thursday's settlement stems from charges brought in 2008 against Cephalon Inc, which was acquired by Teva in 2012. Read more...

TOPICS:

Genelux Announces Positive Phase 1 Data for Viral-Based Cancer Therapy

May 28, 2015 2:29 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Genelux is exploring the area of cancer virotherapy, where one disease is harnessed and used to attack another, with GL-ONC1. Read more...

TOPICS:

Autism Linked to Genetic Mutation – and Researchers Say They Can Undo It

May 28, 2015 12:49 pm | by Seth Augenstein, Digital Reporter | News | Comments

The genetic roots of autism have been investigated for more than a decade, as DNA sequencing has continued to improve. A new, early study points to a particular mutation in mice causing autistic-like behavior, adding to a list of potential causes. Read more...

TOPICS:

Novartis Presents New Data on 21 Medicines, 11 Investigational Compounds at ASCO, EHA

May 28, 2015 12:01 pm | News | Comments

Novartis will highlight the strength of its expanded oncology portfolio in 21 medicines and 11 investigational compounds across more than 185 data presentations at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, May 29-June 2, and the Congress of the European Hematology Association (EHA), June 11-14.  Read more...

TOPICS:

ASCO: Trial Creates Six Percent Weight Loss After Breast Cancer Treatment

May 28, 2015 11:54 am | by University of Colorado Denver | News | Comments

Carrying extra body fat increases the risk for diabetes, heart disease and stroke, and also increases risk of cancer recurrence after a breast cancer diagnosis. A multi-institutional study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015 shows that female breast cancer survivors are able to lose weight through modest lifestyle changes. Read more...

TOPICS:

Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS

May 28, 2015 11:44 am | by ALS Therapy Development Institute | News | Comments

The ALS Therapy Development Institute announced it is directing, via its wholly owned subsidiary, Anelixis Therapeutics, $1.5 million toward the development of a potential treatment for ALS that targets the innate immune system. The funding comes from the $4 million the ALS Therapy Development Institute received from the 2014 social media phenomenon known as the “ALS Ice Bucket Challenge.”  Read more...

TOPICS:

CVS Purchase of Omnicare Fits the Long Term Care Trend: Kalorama

May 28, 2015 11:38 am | News | Comments

According to Kalorama Information, CVS Health Corporation's agreement of May 21 to acquire Omnicare for approximately $12.7 billion fits a prevailing trend in the healthcare industry – to seek to benefit from an aging population. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading